Showing results (61-70 of 127) with videos related to
Sort By:
Pageof 13
Clinical Pharmacology and Therapeutics|November 1, 1981
Measurement of partial agonist activity of pindololS G Carruthers, Y Twum-BarimaJournal of Pharmaceutical Sciences|May 1, 1977
Bioavailability of digoxin-hydroquinone complex: a new oral digoxin formulationF Bochner, D H Huffman, D D Shen, et al.Biopharmaceutics & Drug Disposition|January 1, 1980
Disposition kinetics of disopyramide in patients with renal insufficiencyD D Shen, J L Cunningham, I Shudo, et al.Alcohol (Fayetteville, N.Y.)|February 19, 2000
Reaction of nitroxyl, an aldehyde dehydrogenase inhibitor, with N-acetyl-L-cysteineD W Shoeman, F N Shirota, E G DeMaster, et al.International Journal of Food Sciences and Nutrition|March 1, 1997
The effect of superoxide anion in the production of seven major cholesterol oxidation products in aptoric and protic conditionsJ H Lee, D W Shoeman, S S Kim, et al.Gastroenterology|July 1, 1975
Plasma levels and excretion of estrogens in urine in chronic lever diseaseP J Pentikäinen, L A Pentikäinen, D L Azarnoff, et al.Archives Internationales De Pharmacodynamie Et De Therapie|January 1, 1977
Hepatic effects of some [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio] acetic acid (WY-14,643) analogs in the mouseJ K Reddy, D E Moody, D L Azarnoff, et al.Journal of Biochemical Toxicology|January 1, 1996
Protection against acetaminophen-induced hepatotoxicity by L-CySSME and its N-acetyl and ethyl ester derivativesH T Nagasawa, D W Shoeman, J F Cohen, et al.European Journal of Drug Metabolism and Pharmacokinetics|October 1, 1982
Human metabolism of tolfenamic acid. II. Structure of metabolites and C-13 NMR assignments of fenamatesR G Khalifah, C E Hignite, P J Pentikäinen, et al.Lipids|July 1, 1993
Diabetes increases excretion of urinary malonaldehyde conjugates in ratsD D Gallaher, A S Csallany, D W Shoeman, et al.Pageof 13